Cardiology

Aidoc expands cardiology solutions by bringing Us2.ai's echo AI into proprietary operating system

Retrieved on: 
Friday, October 21, 2022

NEW YORK, Oct. 20, 2022 /PRNewswire/ -- Aidoc, the leading provider of healthcare AI solutions, announced today a partnership with Us2.ai to bring its FDA-cleared and CE Marked AI algorithm to analyze and interpret echocardiograms (echo) into its proprietary aiOS™.

Key Points: 
  • NEW YORK, Oct. 20, 2022 /PRNewswire/ -- Aidoc, the leading provider of healthcare AI solutions, announced today a partnership with Us2.ai to bring its FDA-cleared and CE Marked AI algorithm to analyze and interpret echocardiograms (echo) into its proprietary aiOS.
  • "It's clear hospitals and health systems see significant value in orchestrating AI from a single, trusted partner.
  • Our aiOS allows health systems to think strategically about AI and build an end-to-end intelligence layer across the health system."
  • Aidoc is the leading provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance quality of care.

The Worldwide Medical Education Industry is Expected to Reach $162.5 Billion by 2028

Retrieved on: 
Thursday, October 20, 2022

The Global Medical Education Market Size was valued at USD 90.66 Billion in 2021, and it is expected to reach a value of USD 162.56 Billion by 2028, at a CAGR of 8.70% over the forecast period (2022 - 2028).

Key Points: 
  • The Global Medical Education Market Size was valued at USD 90.66 Billion in 2021, and it is expected to reach a value of USD 162.56 Billion by 2028, at a CAGR of 8.70% over the forecast period (2022 - 2028).
  • Rapid advancements in healthcare infrastructure have piqued the interest of those involved in the global medical education industry.
  • It is also the academic field of subject-didactic training for medical doctors at all levels, including entry-level, post-graduate, and continuing medical education.
  • One of the primary drivers of the Medical Education Market's growth is the increasing number of online medical education programmes.

TeraRecon Announces Launch of its Next Generation Eureka Clinical AI Platform

Retrieved on: 
Thursday, October 20, 2022

CAMBRIDGE, Mass., Oct. 20, 2022 /PRNewswire/ -- TeraRecon, an industry leader in advanced visualization and artificial intelligence (AI) for medical imaging, announced the launch of its next-generation Eureka Clinical AI platform. Designed to support the communication infrastructure and enable collaboration for the entire care team, the platform serves as an end-to-end clinical application integrating multiple AI algorithms and workflows. Eureka Clinical AI supports dual desktop and mobile viewers for cross-specialty collaboration and patient-specific sharing of AI results to accelerate timely access to mission critical images and insights.

Key Points: 
  • The Eureka Clinical AI platform is unique in supporting third-party, customer-developed, and TeraRecon-developed AI algorithms in one unified workflow with clear model-management capabilities.
  • The Eureka Clinical AI platform is supplemented by TR Analytics, providing critical insights to monitor productivity and platform utilization, individual AI algorithm performance.
  • "We are excited with the Eureka Clinical AI platform and its capabilities in executing 3rd party AI algorithms, such as InferVision's InferRead CT Lung AI.
  • With the launch of the Eureka Clinical AI platform, TeraRecon expands into the AI platform market furthering its mission to deliver AI powered solutions that improve outcomes, streamline workflows and reduce burnout for clinicians.

Artificial Intelligence (AI) in Medical Diagnostics Market to Reach $9.38 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Wednesday, October 19, 2022

Artificial intelligence (AI) in medical diagnostics enables medical specialists to quickly and accurately diagnose various diseases, triage critical findings in medical imaging, and flag acute abnormalities.

Key Points: 
  • Artificial intelligence (AI) in medical diagnostics enables medical specialists to quickly and accurately diagnose various diseases, triage critical findings in medical imaging, and flag acute abnormalities.
  • A wide range of research is being conducted to assess AI's accuracy and efficiency in making clinical decisions and enhancing physicians' judgment.
  • The AI in medical diagnostics market has witnessed several new product launches, approvals, partnerships & agreements, and acquisitions in recent years.
  • To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/artificial-intelligence-in-me...
    Artificial Intelligence in Medical Diagnostics Market, by Component
    Artificial Intelligence in Medical Diagnostics Market, by Specialty

Artificial Intelligence (AI) in Medical Diagnostics Market to Reach $9.38 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Wednesday, October 19, 2022

Artificial intelligence (AI) in medical diagnostics enables medical specialists to quickly and accurately diagnose various diseases, triage critical findings in medical imaging, and flag acute abnormalities.

Key Points: 
  • Artificial intelligence (AI) in medical diagnostics enables medical specialists to quickly and accurately diagnose various diseases, triage critical findings in medical imaging, and flag acute abnormalities.
  • A wide range of research is being conducted to assess AI's accuracy and efficiency in making clinical decisions and enhancing physicians' judgment.
  • The AI in medical diagnostics market has witnessed several new product launches, approvals, partnerships & agreements, and acquisitions in recent years.
  • To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/artificial-intelligence-in-me...
    Artificial Intelligence in Medical Diagnostics Market, by Component
    Artificial Intelligence in Medical Diagnostics Market, by Specialty

Karoo Health Appoints Industry Leader as Chief Operating Officer and Accelerates Mission to Improve the Lives of Every Cardiac Patient in America

Retrieved on: 
Wednesday, October 19, 2022

ALBUQUERQUE, N.M., Oct. 19, 2022 /PRNewswire/ -- Karoo Health, the leader in end-to-end, tech-enabled, value-based cardiac care, announced today the hiring of industry veteran Chentelle Lane as COO. Lane will help guide the company's business and operating strategy, including broadening its reach to cardiac patients through partnerships with care organizations and health plans. A proven leader in value-based care operations, Lane was most recently COO of Care Services at Cityblock Health, and has also held executive-level positions at Somatus and naviHealth.

Key Points: 
  • Lane will help guide the company's business and operating strategy, including broadening its reach to cardiac patients through partnerships with care organizations and health plans.
  • A proven leader in value-based care operations, Lane was most recently COO of Care Services at Cityblock Health, and has also held executive-level positions at Somatus and naviHealth.
  • We're excited that Chentelle, one of our industry's great operational leaders, is joining our mission to transform the lives of cardiac patients in America."
  • A leader in tech-enabled, value-based cardiovascular care solutions, Karoo Health empowers the conversion of providers and health plans to a value-based care model.

Rockley Photonics Completes Human Study Demonstrating Promising Intra-Subject Tracking Against Standard Blood Pressure Cuff, Utilizing Its Non-Invasive, Cuffless, and Laser-Based Device

Retrieved on: 
Wednesday, October 19, 2022

Based on its innovative laser-based technology, Rockleys powerful technique for monitoring blood pressure does not rely on subject demographics, unlike many current cuffless blood pressure devices.

Key Points: 
  • Based on its innovative laser-based technology, Rockleys powerful technique for monitoring blood pressure does not rely on subject demographics, unlike many current cuffless blood pressure devices.
  • Data collected in Rockleys proof of concept blood pressure study provides promising results.
  • An in-line arterial study with an accurate pressure monitoring catheter reference on 30 subjects is also planned for this fall.
  • Results from Rockleys blood pressure study are presented in a new whitepaper: Intra-Subject Blood Pressure Tracking Using an Innovative Cuffless Laser-Based Technology, available for download on Rockleys website .

Prodigy Care Services Announces its ProdigyRx Clinical Panel

Retrieved on: 
Wednesday, October 19, 2022

Prodigy Care Services has formed a clinical panel to provide insight and guidance to its workers compensation pharmacy benefits manager, ProdigyRx.

Key Points: 
  • Prodigy Care Services has formed a clinical panel to provide insight and guidance to its workers compensation pharmacy benefits manager, ProdigyRx.
  • Our clinical panelists are accomplished Pharm.Ds, thought leaders and practicing clinical professionals who understand the clinical needs of patients in various practice specialties, said Prodigy CEO and Co-founder Del Doherty, Pharm.D., Ph.D., MBA.
  • Vice President of Clinical Services at PCCA , Dr. Day has over 15 years experience in clinical and compounding pharmacy.
  • Dr. Nguyen has over a decade of health system experience, focused on population health, pharmacy operations, clinical services, and healthcare leadership.

OSF HealthCare Implements CareSignal’s Deviceless Remote Patient Monitoring® to Extend Care to Rising-Risk Patient Populations

Retrieved on: 
Wednesday, October 19, 2022

OSF HealthCare selected CareSignal , a Lightbeam company, to offer Deviceless Remote Patient Monitoring (RPM) and help power its enterprise-wide digital health solution, OSF OnCall Connect .

Key Points: 
  • OSF HealthCare selected CareSignal , a Lightbeam company, to offer Deviceless Remote Patient Monitoring (RPM) and help power its enterprise-wide digital health solution, OSF OnCall Connect .
  • But through the addition of CareSignals Deviceless RPM technology, OSF OnCall Connect can now scale to reach an additional 117,000 rising-risk patients with chronic conditions.
  • OSF OnCall, the digital arm of Peoria, Illinois-based OSF HealthCare, offers unique, full-scale digital health and convenient care options.
  • OSF OnCall also represents other at-home and hospital-based digital care including remote monitoring, intensive care and hospitalist programs, as well as a digital hospital option.

AccurKardia and Mawi Announce Strategic Collaboration to Provide Automated ECG Analytics for the new Mawi Watch

Retrieved on: 
Wednesday, October 19, 2022

As part of the collaboration, AccurKardias cutting edge innovation in device agnostic automated ECG analytics will complement Mawis proven expertise in designing, developing and deploying superior cardiac monitoring devices and wearables.

Key Points: 
  • As part of the collaboration, AccurKardias cutting edge innovation in device agnostic automated ECG analytics will complement Mawis proven expertise in designing, developing and deploying superior cardiac monitoring devices and wearables.
  • Joining forces will provide our new Mawi Watch with next level ECG analytics as we create a fully integrated solution for chronic patients cardiac remote monitoring, said Ron Fridman , the CEO of Mawi.
  • AccurKardia provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies.
  • Mawi Watch comes with RPM software, which provides healthcare practitioners with real-time health data and high-risk alerts.